Therapeutic Group: Monoclonal Antibody Presentation Advixa 40: Each pre-filled syringe contains 0.8 ml sterile solution of Adalimumab 40 mg. Description Adalimumab is a recombinant human IgG1 monoclonal antibody specific for human tumor necrosis factor (TNF). Adalimumab binds specifically to TNF-alpha and blocks its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab also […]